New clinical research finds that THC-containing cannabis may help relieve migraine pain, while CBD alone shows less promise.

Migraine can bring severe headaches, nausea, and sensitivity to light or sound. Although many patients report using cannabis for relief, controlled clinical research has been limited.

A 2026 study published in Headache offers new evidence that certain cannabis formulations may help treat an active migraine attack.

What the study found

Researchers at the University of California San Diego enrolled 92 adults in a randomized, placebo-controlled trial comparing vaporized THC, CBD, a THC/CBD combination, and placebo.

Participants treated 247 migraine attacks, allowing researchers to compare the effects of different cannabinoids.

Two hours after treatment:

  • 67% of attacks treated with THC/CBD experienced pain relief, compared with 47% receiving placebo.
  • 35% of attacks treated with THC/CBD were pain-free, compared with 16% receiving placebo.
  • 60% experienced relief from their most bothersome migraine symptom, compared with 35% receiving placebo.

Some benefits lasted 24–48 hours.

Does combining THC and CBD work better?

THC alone provided pain relief in approximately 69% of treated attacks, also outperforming placebo.

CBD alone did not significantly outperform placebo on the study’s main outcomes.

The THC/CBD combination improved more measures than THC alone, including complete pain relief and relief from the most bothersome symptom.

However, researchers did not establish that the combination was statistically superior to THC alone.

The findings suggest THC plays an important role in acute migraine relief, while the added benefit of CBD remains uncertain.

What other research shows

A 2026 study from the UK Medical Cannabis Registry followed 203 adults prescribed cannabis-based medicines for migraine.

Participants reported improvements in headache impact, sleep, and quality of life over follow-up periods extending to two years.

However, the study did not include a placebo group, so researchers could not determine whether cannabis caused those improvements.

Together, the studies offer encouraging findings, but more controlled research is needed.

What patients should know

The UC San Diego trial tested vaporized cannabis for treating an active migraine, not daily cannabis use to prevent headaches.

Results cannot automatically be applied to edibles, tinctures, or other products with different cannabinoid concentrations.

THC can cause intoxication, dizziness, and impaired coordination. Patients should discuss cannabis use with their healthcare providers, particularly when taking other medications.

Keeping a migraine journal can help track headache frequency, symptoms, triggers, and treatment response.

The takeaway: THC-containing cannabis may help relieve acute migraine symptoms, but researchers have not yet established the safest or most effective formulation, dose, or long-term treatment approach.

No more articles